glp-1 receptor agonist brands list Market Overview: Agonists and the Obesity Market | Blog New GLP-1 Guidelines for Type
Description
Clinical Take-Home Messages GLP-1RAs are no longer diabetes-only drugs. They are becoming: Obesity therapies Cardiovascular protective agents Anti-inflammatory therapies Neuroprotective candidates Metabolic disease modifiers Conclusion We are witnessing a historic transition in medicine
[DOI] [PubMed] [Google Scholar] 268.Ashcroft F.M., Rorsman P
Lancet 389 , 13991409 (2017)
It can help you stay fuller longer
